Therefore, we surmise that neuroblastoma, particularly high-risk tumors, are addicted to and depend on XIAP for survival, and that targeting XIAP rather than other IAPs can yield specific and effective apoptotic cell death. This evidence concerns the gene XIAP and neuroblastoma.